These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Valvular heart disease in Parkinson's disease vs. controls: An echocardiographic study. Peralta C; Wolf E; Alber H; Seppi K; Müller S; Bösch S; Wenning GK; Pachinger O; Poewe W Mov Disord; 2006 Aug; 21(8):1109-13. PubMed ID: 16622856 [TBL] [Abstract][Full Text] [Related]
24. [Clinicomorphological features of nephropathy in primary and secondary antiphospholipid syndrome]. Kozlovskaia NL; Shilov EM; Meteleva NA; Varshavskiĭ VA; Kushnir VV; Shakhnova EA; Miroshnichenko NG; Serova AG; Nesterova SG Ter Arkh; 2007; 79(6):16-25. PubMed ID: 17684961 [TBL] [Abstract][Full Text] [Related]
25. Valvular lesions in patients with systemic lupus erythematosus and antiphospholipid syndrome: an old disease but a persistent challenge. Ferreira E; Bettencourt PM; Moura LM Rev Port Cardiol; 2012 Apr; 31(4):295-9. PubMed ID: 22386150 [TBL] [Abstract][Full Text] [Related]
26. Echocardiographic evaluation of patients with primary antiphospholipid syndrome. Espínola-Zavaleta N; Vargas-Barrón J; Colmenares-Galvis T; Cruz-Cruz F; Romero-Cárdenas A; Keirns C; Amigo MC Am Heart J; 1999 May; 137(5):973-8. PubMed ID: 10220649 [TBL] [Abstract][Full Text] [Related]
27. Cardiac valve replacement in patients with antiphospholipid syndrome. Erdozain JG; Ruiz-Irastorza G; Segura MI; Amigo MC; Espinosa G; Pomar JL; Perez-Valero I; Ateka-Barrutia O; Khamashta MA Arthritis Care Res (Hoboken); 2012 Aug; 64(8):1256-60. PubMed ID: 22422594 [TBL] [Abstract][Full Text] [Related]
28. Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus. Pérez-Vázquez ME; Villa AR; Drenkard C; Cabiedes J; Alarcón-Segovia D J Rheumatol; 1993 Mar; 20(3):437-42. PubMed ID: 8478848 [TBL] [Abstract][Full Text] [Related]
29. Risk factors for arterial thrombosis in antiphospholipid syndrome. Matyja-Bednarczyk A; Swadźba J; Iwaniec T; Sanak M; Dziedzina S; Ćmiel A; Musiał J Thromb Res; 2014 Feb; 133(2):173-6. PubMed ID: 24321419 [TBL] [Abstract][Full Text] [Related]
32. [Antiphospholipid syndrome. The use of transesophageal echocardiography]. Cervera Miguel JI; Navarro Ibáñez V; Calabuig Muñoz E; Tordera Higón P; Montero Alonso M An Med Interna; 2003 Oct; 20(10):532-3. PubMed ID: 14585041 [TBL] [Abstract][Full Text] [Related]
33. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. Roldan CA; Shively BK; Crawford MH N Engl J Med; 1996 Nov; 335(19):1424-30. PubMed ID: 8875919 [TBL] [Abstract][Full Text] [Related]
35. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Cervera R; Serrano R; Pons-Estel GJ; Ceberio-Hualde L; Shoenfeld Y; de Ramón E; Buonaiuto V; Jacobsen S; Zeher MM; Tarr T; Tincani A; Taglietti M; Theodossiades G; Nomikou E; Galeazzi M; Bellisai F; Meroni PL; Derksen RH; de Groot PG; Baleva M; Mosca M; Bombardieri S; Houssiau F; Gris JC; Quéré I; Hachulla E; Vasconcelos C; Fernández-Nebro A; Haro M; Amoura Z; Miyara M; Tektonidou M; Espinosa G; Bertolaccini ML; Khamashta MA; Ann Rheum Dis; 2015 Jun; 74(6):1011-8. PubMed ID: 24464962 [TBL] [Abstract][Full Text] [Related]
36. [Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: a report of 3 new cases and a review of the literature]. Blanco Y; Ramos-Casals M; García-Carrasco M; Cervera R; Font J; Ingelmo M Rev Clin Esp; 1999 Sep; 199(9):586-8. PubMed ID: 10568151 [TBL] [Abstract][Full Text] [Related]
37. The prevalence of valvular abnormalities in patients who were referred for echocardiographic examination with a primary diagnosis of "heart murmur". Movahed MR; Ebrahimi R Echocardiography; 2007 May; 24(5):447-51. PubMed ID: 17456061 [TBL] [Abstract][Full Text] [Related]
38. Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine. Hensrud DD; Connolly HM; Grogan M; Miller FA; Bailey KR; Jensen MD Mayo Clin Proc; 1999 Dec; 74(12):1191-7. PubMed ID: 10593346 [TBL] [Abstract][Full Text] [Related]
39. Transcatheter aortic valve replacement for advanced valvular disease in active SLE and APS. Bert JS; Abdullah M; Dahle TG; Gertner E Lupus; 2013 Sep; 22(10):1046-9. PubMed ID: 23884983 [TBL] [Abstract][Full Text] [Related]
40. The heart in the primary antiphospholipid syndrome. Badui E; Solorio S; Martinez E; Bravo G; Enciso R; Barile L; Gutierrez-Vogel S; Miranda J Arch Med Res; 1995; 26(2):115-20. PubMed ID: 7620275 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]